The Certificate in Psychedelic Therapy and Integration equips clinicians with essential skills and knowledge for effective psychedelic-assisted therapy.
Fluence
English
5 hours
This Certificate in Psychedelic Therapy and Integration program from Fluence provides clinicians with a foundational education in psychedelic-assisted therapy and integration. Over six weeks, students will learn about core clinical concepts, preparation, assisting psychedelic experiences, and integration.
The program includes live online training, on-demand video content, and case-oriented learning through roleplays. It equips healthcare professionals with the skills needed to practice psychedelic therapy, explore regulatory landscapes, and prepare for specialization in various psychedelic-assisted therapies.
Clinicians and healthcare professionals
Not specified in the source text.
Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.
By Ayahuasca Wisdom
This page outlines 11 ways ayahuasca integration can support the post-experience process. It frames integration as a practical space to explore messages, reflect on what arose, and define next steps with a therapist, consultant, or coach.
By Synthesis
An 8-day immersive apprenticeship retreat in the Netherlands focused on ethical psychedelic facilitation and group space-holding. Participants observe, support, and reflect within a clinically informed, somatically intelligent training structure.
By MIND Foundation
Augmented Psychotherapy Training (APT) is a 15-month professional training in psychedelic therapy offered by MIND Foundation. It focuses on legal, safe, and evidence-based practice.
Next cohort: Nov 7, 2026